作者: Bomi Kim , Jae Kyung Myung , Ja Hee Seo , Chul-Kee Park , Sun Ha Paek
DOI: 10.1016/J.JNS.2010.03.019
关键词:
摘要: Abstract Glioblastoma (GBM) is a malignant CNS neoplasm. The prognosis of GBM may be influenced by the molecules p53/MDM2/p14ARF, RB/p16INK4a, and EGFR/PTEN/protein kinase B (PKB)/phosphoinositide 3-kinase (PI3K) pathways. We studied expression status specific molecular markers in GBMs immunohistochemistry (IHC) FISH correlation with clinical outcomes. positivity EGFR those IHC pharmDx Zymed antibodies were 64.9%, 73.5%, 43.4%, respectively. antibody was more sensitive but less than antibody. p53 overexpression, MDM2 expression, p16 loss, PTEN PKB PI3K found 48.2%, 26.5%, 56.6%, 21.4%, 15.7% 6.0%, significantly, although not completely, correlated immunoexpression also showed positive correlation. On multivariate survival studies, old age (≥ 40 yrs) bilaterality independent unfavorable factors ( p = 0.031).